Berberine ursodeoxycholate for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 6 registered trials.

Why this status

  1. 5 Nov 2023: Trial started, NCT06350890
  2. 13 Nov 2023: Trial started, NCT06353347
  3. 8 Apr 2024: Trial registered, NCT06350890
  4. 9 Apr 2024: Trial registered, NCT06353347
  5. 16 May 2024: Trial registered, NCT06415773
  6. 4 Jun 2024: Trial started, NCT06415773

The trials

NCT03656744: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

State
Completed
Phase
Phase 2
People
101 taking part
Started
26 Nov 2018
Primary completion
7 Feb 2020
Arms
500mg HTD1801, bid, 1000mg HTD1801, bid
Results
Posted on the registry
  1. 4 Sep 2018: Trial registered
  2. 26 Nov 2018: Trial started
  3. 9 Mar 2020: Trial completed
  4. 29 Dec 2021: Trial results posted

NCT05623189: HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

State
Completed
Phase
Phase 2
People
218 taking part
Started
27 Dec 2022
Primary completion
31 Mar 2025
Arms
HTD1801
Results
None posted
  1. 21 Nov 2022: Trial registered
  2. 27 Dec 2022: Trial started
  3. 31 Mar 2025: Trial completed

NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

State
Completed
Phase
Phase 3
People
408 taking part
Started
5 Nov 2023
Primary completion
12 Dec 2024
Arms
HTD1801
Results
None posted
  1. 5 Nov 2023: Trial started
  2. 8 Apr 2024: Trial registered
  3. 4 Aug 2025: Trial completed

NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

State
Completed
Phase
Phase 3
People
551 taking part
Started
13 Nov 2023
Primary completion
12 Dec 2024
Arms
HTD1801
Results
None posted
  1. 13 Nov 2023: Trial started
  2. 9 Apr 2024: Trial registered
  3. 30 Jul 2025: Trial completed

NCT06411275: A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

State
Completed
Phase
Phase 2
People
113 taking part
Started
31 Mar 2022
Primary completion
17 Jan 2023
Arms
HTD1801 500 mg, HTD1801 1000 mg
Results
None posted
  1. 31 Mar 2022: Trial started
  2. 17 Jan 2023: Trial completed
  3. 13 May 2024: Trial registered

NCT06415773: Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

State
Completed
Phase
Phase 3
People
367 taking part
Started
4 Jun 2024
Primary completion
13 Jun 2025
Arms
HTD1801
Results
None posted
  1. 16 May 2024: Trial registered
  2. 4 Jun 2024: Trial started
  3. 25 Jul 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.